Interleukin-10: Cytokines in Anti-inflammation and Tolerance
暂无分享,去创建一个
A. O’Garra | P. S. Redford | L. Gabryšová | A. Howes | Anne O'Garra | Leona Gabryšová | Ashleigh Howes | Philippa Stimpson | Paul S. Redford | Philippa J Stimpson
[1] S. Matsuda,et al. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. , 2008, Blood.
[2] Kevin Marsh,et al. Immunity to malaria: more questions than answers , 2008, Nature Immunology.
[3] D. Strachan,et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility , 2008, Nature Genetics.
[4] Yi Luo,et al. Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer. , 2012, The Journal of urology.
[5] Yi Luo. Blocking IL-10 enhances bacillus Calmette-Guérin induced T helper Type 1 immune responses and anti-bladder cancer immunity , 2012, Oncoimmunology.
[6] Richard A Flavell,et al. The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells , 1997, Cell.
[7] Y. Belkaid,et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.
[8] C. Hunter,et al. The immunobiology of IL-27. , 2012, Advances in immunology.
[9] P. Murray. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. , 2006, Current opinion in pharmacology.
[10] G. Trinchieri,et al. CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .
[11] R. J. Hocking,et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.
[12] S. Gordon,et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.
[13] Margarida Saraiva,et al. Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose , 2009, Immunity.
[14] R. Coffman,et al. Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.
[15] N. Gow,et al. Pattern recognition: recent insights from Dectin-1 , 2009, Current opinion in immunology.
[16] W. Ouyang,et al. Signaling and transcription in T helper development. , 2000, Annual review of immunology.
[17] P. Blackshear,et al. The p38 MAPK pathway inhibits tristetraprolin‐directed decay of interleukin‐10 and pro‐inflammatory mediator mRNAs in murine macrophages , 2009, FEBS letters.
[18] R. de Waal Malefyt,et al. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). , 2002, Cytokine & growth factor reviews.
[19] K. Rajewsky,et al. T Cell–specific Inactivation of the Interleukin 10 Gene in Mice Results in Enhanced T Cell Responses but Normal Innate Responses to Lipopolysaccharide or Skin Irritation , 2004, The Journal of experimental medicine.
[20] D. Sacks,et al. CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis , 2007, The Journal of experimental medicine.
[21] T. Lawrence,et al. The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression , 2008, Nature Immunology.
[22] A. Rudensky,et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. , 2011, Immunity.
[23] C. Hawrylowicz,et al. Strategies for use of IL‐10 or its antagonists in human disease , 2008, Immunological reviews.
[24] Booki Min,et al. Conditional deletion of Gata3 shows its essential function in TH1-TH2 responses , 2004, Nature Immunology.
[25] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[26] I. Orme,et al. In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.
[27] T. Beaty,et al. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. , 1996, Journal of the National Cancer Institute.
[28] Tom R. Mayo,et al. Genome-wide Analysis Identifies Interleukin-10 mRNA as Target of Tristetraprolin* , 2008, Journal of Biological Chemistry.
[29] M. Leach,et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. , 1996, The Journal of clinical investigation.
[30] Ching Li,et al. A Defect in Interleukin-10 Leads to Enhanced Malarial Disease in Plasmodium chabaudi chabaudi Infection in Mice , 1999, Infection and Immunity.
[31] E. Gambineri,et al. Role of regulatory T cells and FOXP3 in human diseases. , 2007, The Journal of allergy and clinical immunology.
[32] G. Trinchieri,et al. In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity. , 2004, Novartis Foundation symposium.
[33] W. Leonard,et al. Jaks and STATs: biological implications. , 1998, Annual review of immunology.
[34] T. Mosmann,et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. , 1990, Science.
[35] M. Conde,et al. TheMycobacterium tuberculosis Complex-Restricted Genecfp32 Encodes an Expressed Protein That Is Detectable inTuberculosis Patients and Is Positively Correlated with PulmonaryInterleukin-10 , 2003, Infection and Immunity.
[36] Samir K. Brahmachari,et al. Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a , 2009, Proceedings of the National Academy of Sciences.
[37] K. Stuhlmeier,et al. The TSC-mTOR signaling pathway regulates the innate inflammatory response. , 2008, Immunity.
[38] J. Woodgett,et al. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. , 2006, Immunity.
[39] D. Levy,et al. IL-21 Mediates Suppressive Effects via Its Induction of IL-101 , 2009, The Journal of Immunology.
[40] J. Ruland,et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.
[41] G. Bancroft,et al. Blockade of IL-10 Signaling during Bacillus Calmette-Guérin Vaccination Enhances and Sustains Th1, Th17, and Innate Lymphoid IFN-γ and IL-17 Responses and Increases Protection to Mycobacterium tuberculosis Infection , 2012, The Journal of Immunology.
[42] M. Howard,et al. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice , 1994, The Journal of experimental medicine.
[43] D. Leduc,et al. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. , 1995, The Journal of clinical investigation.
[44] Xia Zhang,et al. Dynamic and Transient Remodeling of the Macrophage IL-10 Promoter during Transcription1 , 2006, The Journal of Immunology.
[45] D. Wraith,et al. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10–secreting Th1 cells , 2009, The Journal of experimental medicine.
[46] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[47] G. Bancroft,et al. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung , 2010, European journal of immunology.
[48] Laurie H Glimcher,et al. A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.
[49] Francis J. Huber,et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. , 2011, Immunity.
[50] C. Akdis,et al. Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.
[51] David L. Williams,et al. Syk‐dependent ERK activation regulates IL‐2 and IL‐10 production by DC stimulated with zymosan , 2007, European journal of immunology.
[52] J. Langhorne,et al. T cell-derived IL-10 and its impact on the regulation of host responses during malaria. , 2012, International journal for parasitology.
[53] D. McGavern,et al. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection , 2008, The Journal of experimental medicine.
[54] S. Rutz,et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. , 2011, Annual review of immunology.
[55] D. Flaherty,et al. Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.
[56] D. Sacks,et al. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. , 2007, Trends in immunology.
[57] T. Mosmann,et al. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.
[58] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[59] Frank Kaiser,et al. TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells , 2009, The Journal of experimental medicine.
[60] S. Fillatreau. Novel regulatory functions for Toll‐like receptor‐activated B cells during intracellular bacterial infection , 2011, Immunological reviews.
[61] O. Leavy,et al. Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics1 , 2008, The Journal of Immunology.
[62] P. Barry,et al. Virus-Encoded Homologs of Cellular Interleukin-10 and Their Control of Host Immune Function , 2016 .
[63] F. Powrie,et al. Regulatory lymphocytes and intestinal inflammation. , 2009, Annual review of immunology.
[64] S. Wenzel,et al. Interleukin-10 regulation in normal subjects and patients with asthma. , 1996, Journal of Allergy and Clinical Immunology.
[65] B. Pulendran,et al. A Toll-Like Receptor 2 Ligand Stimulates Th2 Responses In Vivo, via Induction of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and c-Fos in Dendritic Cells 1 , 2004, The Journal of Immunology.
[66] G. Berry,et al. CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. , 2002, The Journal of allergy and clinical immunology.
[67] F. Marincola,et al. Interleukin‐10 and the immune response against cancer: a counterpoint , 2005, Journal of leukocyte biology.
[68] D. Raoult,et al. The two faces of interleukin 10 in human infectious diseases. , 2006, The Lancet. Infectious diseases.
[69] Lisa M. Toney,et al. Regulation of IL-10 Gene Expression in Th2 Cells by Jun Proteins1 , 2005, The Journal of Immunology.
[70] Margarida Saraiva,et al. The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.
[71] Gisen Kim,et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.
[72] Richard A. Flavell,et al. Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection , 2007, The Journal of experimental medicine.
[73] Georg Kraal,et al. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.
[74] Fiona Powrie,et al. Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.
[75] C. Hawrylowicz,et al. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma , 2005, Nature Reviews Immunology.
[76] CM Filippi,et al. IL‐10 and the resolution of infections , 2008, The Journal of pathology.
[77] A. O’Garra,et al. The role of IL-10 in immune regulation during M. tuberculosis infection , 2011, Mucosal Immunology.
[78] S. Rutz,et al. Notch regulates IL-10 production by T helper 1 cells , 2008, Proceedings of the National Academy of Sciences.
[79] P. Murray. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[80] R. Sartor,et al. Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.
[81] Christopher A Hunter,et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 , 2007, Nature Immunology.
[82] Christoph Wilhelm,et al. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset , 2008, Nature Immunology.
[83] A. Sher,et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.
[84] D. Littman,et al. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.
[85] T. Wynn,et al. IL-10 and the Dangers of Immune Polarization: Excessive Type 1 and Type 2 Cytokine Responses Induce Distinct Forms of Lethal Immunopathology in Murine Schistosomiasis , 2000, The Journal of Immunology.
[86] C. Mauri,et al. Immune regulatory function of B cells. , 2012, Annual review of immunology.
[87] P. Handford,et al. The CD46 and Jagged1 interaction is critical for human T helper 1 immunity , 2012, Nature Immunology.
[88] T. Mosmann,et al. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. , 1990, Science.
[89] C. Weaver,et al. Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation , 2008, Immunological reviews.
[90] Werner Müller,et al. IL-27 Promotes IL-10 Production by Effector Th1 CD4+ T Cells: A Critical Mechanism for Protection from Severe Immunopathology during Malaria Infection , 2012, The Journal of Immunology.
[91] Zhihong Wu,et al. c-Maf Regulates IL-10 Expression during Th17 Polarization1 , 2009, The Journal of Immunology.
[92] D. Miranda-Saavedra,et al. Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages. , 2012, Blood.
[93] C. Hawrylowicz,et al. Regulatory T cells in asthma. , 2009, Immunity.
[94] F. Marincola,et al. The dual role of IL-10. , 2003, Trends in immunology.
[95] H. Rugo,et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. , 1990, International immunology.
[96] M. Lotze,et al. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice. , 1996, Journal of immunology.
[97] A. Sher,et al. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. , 1998, Journal of immunology.
[98] A. O’Garra,et al. GATA-3 Directly Remodels the IL-10 Locus Independently of IL-4 in CD4+ T Cells , 2006, The Journal of Immunology.
[99] J. Wain,et al. A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion , 2006, Proceedings of the National Academy of Sciences.
[100] Genhong Cheng,et al. Cutting Edge: Involvement of the Type I IFN Production and Signaling Pathway in Lipopolysaccharide-Induced IL-10 Production1 , 2007, The Journal of Immunology.
[101] Y. Belkaid,et al. The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.
[102] A. Schäffer,et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.
[103] M. Roederer,et al. IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform , 2010, The Journal of experimental medicine.
[104] Steve Gerondakis,et al. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[105] M. Gilliet,et al. Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells , 2002, The Journal of experimental medicine.
[106] Jae-Geun Yoon,et al. Role of Mitogen-Activated Protein Kinases in CpG DNA-Mediated IL-10 and IL-12 Production: Central Role of Extracellular Signal-Regulated Kinase in the Negative Feedback Loop of the CpG DNA-Mediated Th1 Response1 , 2002, The Journal of Immunology.
[107] M. Dallman,et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. , 2005, The Journal of clinical investigation.
[108] Margarida Saraiva,et al. Identification of a Macrophage-Specific Chromatin Signature in the IL-10 Locus1 , 2005, The Journal of Immunology.
[109] R. North,et al. Immunity to tuberculosis. , 2003, Annual review of immunology.
[110] H. Weiner,et al. IL-10 is critical in the regulation of automimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4 deficient and transgenic mice , 1998, Journal of Neuroimmunology.
[111] H. So,et al. Interaction of Ets-1 with HDAC1 Represses IL-10 Expression in Th1 Cells , 2012, The Journal of Immunology.
[112] T. Wynn. Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.
[113] M. Feldmann,et al. IL-10 inhibits transcription elongation of the human TNF gene in primary macrophages , 2010, The Journal of experimental medicine.
[114] A. Trautmann,et al. Modifications of CD8+ T cell function during in vivo memory or tolerance induction. , 1998, Immunity.
[115] S. Pestka,et al. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[116] W. Haining,et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade , 2006, The Journal of experimental medicine.
[117] S. Akira,et al. Macrophages and Myeloid Dendritic Cells, but Not Plasmacytoid Dendritic Cells, Produce IL-10 in Response to MyD88- and TRIF-Dependent TLR Signals, and TLR-Independent Signals1 , 2006, The Journal of Immunology.
[118] Tariq Ahmad,et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.
[119] L. Teyton,et al. Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.
[120] M. Feldmann,et al. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. , 1998, Journal of immunology.
[121] Hyun-Dong Chang,et al. Expression of IL‐10 in Th memory lymphocytes is conditional on IL‐12 or IL‐4, unless the IL‐10 gene is imprinted by GATA‐3 , 2007, European journal of immunology.
[122] K. Lockridge,et al. Primate cytomegaloviruses encode and express an IL-10-like protein. , 2000, Virology.
[123] I. Ho,et al. Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses , 2005, The Journal of experimental medicine.
[124] J. Turner,et al. Interleukin-10 and Immunity against Prokaryotic and Eukaryotic Intracellular Pathogens , 2011, Infection and Immunity.
[125] M. Howard,et al. Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10 , 1992, European journal of immunology.
[126] Xia Zhang,et al. NF-κB1 (p50) Homodimers Differentially Regulate Pro- and Anti-inflammatory Cytokines in Macrophages* , 2006, Journal of Biological Chemistry.